AIM: £3.50 (+0.09) | Nasdaq: $21.77 (-0.26)
News Archive

Our latest announcements or presentations are available by selecting the desired News Type.

Announcements can be further filtered by topic using the News Topic check boxes.

 

The full text of all announcements are available for download in the form of PDF files.  For convenience, the text of some announcements have been partially or fully rendered as web pages.  Should any inconsistencies exist, the PDF version shall prevail.

News Type
Presentations
RNS Announcements
News Topics
Commercial Platform
Group
Innovation Platform
Regulatory Notice
1
2345678910111213
found Documents: 601
Event | 13 Sep 2019

Morgan Stanley China Healthcare Corporate Day
Venue: Morgan Stanley Office, Hong Kong
Event | 13 Sep 2019

Macquarie China Healthcare Corporate Day
Macquarie Office, Hong Kong
Presentations, Scientific Publications | 9 Sep 2019

WCLC 2019: Phase III Fruquintinib v.s. Placebo in Advanced Non-Small Cell Lung Cancer (FALUCA)
MA14.05 - A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)   Venue: IASLC 2019 World Conference on Lung Cancer in Barcelona, Spain Session:MA14 - The Adequate MTarget
Read More
Download Presentation (PDF)
Corporate presentations, Event | 9 Sep 2019

CLSA Investors' Forum 2019
Grand Hyatt, Hong Kong
Download Presentation (PDF)
Event | 5 Sep 2019

Morgan Stanley 17th Annual Global Healthcare Conference
Location: New York, NY, United States Time: 09:55 AM EDT >> Click here for the webcast  
Read More
Group, Press Releases, RNS Announcements | 3 Sep 2019

Chi-Med to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
London: Tuesday, September 3, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that Christian Hogg, Chief Executive Officer, will participate in a fireside chat at Morgan Stanley 17th Annual Global Healthcare C
Read More
Download Press Release (PDF)
Innovation Platform, Press Releases, RNS Announcements | 3 Sep 2019

Chi-Med Initiates an International Phase I/Ib Trial of HMPL-689 in Patients with Advanced Relapsed or Refractory Lymphoma
London: Tuesday, September 3, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated an international Phase I/Ib study of HMPL-689, its novel, highly selective and potent small molecule phosphoinositide-3 kinase delta
Read More
Download Press Release (PDF)
Regulatory Notice, RNS Announcements | 30 Aug 2019

Total Voting Rights
London: Friday, August 30, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at August 30, 2019, the issued share capital of Chi-Med consisted of 666,777,450 ordinary shares of US$0.10 each, w
Read More
View Announcement (PDF)
Innovation Platform, Press Releases, RNS Announcements | 23 Aug 2019

Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
London: Friday, August 23, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor, in patients with immune thrombocytopenia (“ITP”
Read More
Download Press Release (PDF)
Regulatory Notice, RNS Announcements | 20 Aug 2019

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hut
Read More
View Announcement (PDF)
Interim Reports | 14 Aug 2019

Interim Report 2019
Contents Corporate Information Contents 1 Financial Highlights 2 Operating Highlights 3 Chairman’s Statement6 6 Financial Review 7 Operations Review     Innovation Platform     Comme
Read More
View Full Report (PDF)
Regulatory Notice, RNS Announcements | 30 Jul 2019

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hut
Read More
View Announcement (PDF)
Corporate presentations, Event | 30 Jul 2019

2019 Half-Year Financial Results
Announcement released: 7am BST (2pm HKT/2am EDT)  >> See announcement here Presentation webcast & call: 9am BST (4pm HKT/4am EDT) >> Click here for the webcast US conference call: 9am EDT (2pm BST/9pm HKT)
Read More
Download Presentation (PDF)
Group, RNS Announcements | 30 Jul 2019

Chi-Med Reports 2019 Interim Results and Provides Updates on Key Clinical Programs
London: Tuesday, July 30, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces its unaudited financial results for the six months ended June 30, 2019 and provides updates on key clinical programs.  Major highlight
Read More
Download Announcement (PDF)
Regulatory Notice, RNS Announcements | 3 Jul 2019

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hutch
Read More
View Announcement (PDF)
Regulatory Notice, RNS Announcements | 3 Jul 2019

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hut
Read More
View Announcement (PDF)
Group, RNS Announcements | 3 Jul 2019

Chi-Med to Announce 2019 Half-Year Financial Results
London: Wednesday, July 3, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) will be announcing its interim results for the six months ended June 30, 2019 on Tuesday, July 30, 2019 at 7:00 am British Summer Time (BST) (2:00 pm
Read More
View Announcement (PDF)
Regulatory Notice, RNS Announcements | 28 Jun 2019

Blocklisting Six Monthly Return
London: Friday, June 28, 2019: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) announces the following blocklisting six monthly return:   1. Name of applicant: Hutchison China MediTech Limite
Read More
Download Announcement (PDF)
Group, RNS Announcements | 28 Jun 2019

Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION London: June 28, 2019: Hutchison China MediTech Limited (“
Read More
Download Announcement (PDF)
Group, RNS Announcements | 27 Jun 2019

Chi-Med Announces Secondary Offering of American Depositary Shares
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION London: June 27, 2019: Hutchison China MediTech Limited (“
Read More
Download Announcement (PDF)
Innovation Platform, Press Releases, RNS Announcements | 14 Jun 2019

Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim Analysis in Advanced Non-Pancreatic Neuroendocrine Tumors in China and Will Stop Early
London: Friday, June 14, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that the independent Data Monitoring Committee (“IDMC”) of the Phase III pivotal study of surufatinib in advanced neuroendocrine tum
Read More
Download Press Release (PDF)
Regulatory Notice, RNS Announcements | 12 Jun 2019

Block Admission Applications and Total Voting Rights
London: Wednesday, June 12, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that the following applications have been made to the London Stock Exchange plc for the block admission of ordinary shares, par value
Read More
View Announcement (PDF)
Regulatory Notice, RNS Announcements | 6 Jun 2019

Disclosure Update
London: Thursday, June 6, 2019: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) today filed the Post Hearing Information Pack (the “PHIP”) with the Stock Exchange of Hong Kong Limited (“SEHK”) in connec
Read More
Download Announcement (PDF)
Presentations, Scientific Publications | 1 Jun 2019

Clin Cancer Res: Surufatinib in advanced, well-differentiated neuroendocrine tumors
Surufatinib in advanced well-differentiated neuroendocrine tumors: a multicenter, 3 single-arm, open-label, phase Ib/II trial Jianming Xu, Jie Li, Chunmei Bai, Nong Xu, Zhiwei Zhou, Zhiping Li, Caicun Zhou, Ru Jia, Ming Lu, Yuejuan Cheng, Chenyu Mao
Read More
Corporate presentations, Event, Presentations | 31 May 2019

Morgan Stanley Annual China Summit 2019
Rosewood Beijing
Download English Presentation (PDF)Download Chinese Presentation (PDF)
Group, RNS Announcements | 29 May 2019

Results of Extraordinary General Meeting
London: Wednesday, May 29, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that the ordinary resolution and special resolution put to its Extraordinary General Meeting (“EGM”) held on May 29, 2019 were dul
Read More
Download Announcement (PDF)
Regulatory Notice, RNS Announcements | 22 May 2019

Grant of Share Options under Share Option Scheme
London: Wednesday, May 22, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announces that on May 21, 2019, it granted share options under the Share Option Scheme conditionally adopted by Chi-Med at its Annual General Meeting
Read More
View Announcement (PDF)
Event | 9 May 2019

Macquarie Greater China Conference 2019
Island Shangri-La Hotel, Hong Kong
Corporate presentations, Event, Presentations | 8 May 2019

J.P. Morgan Global China Summit 2019
China World Summit Wing Hotel, Beijing
Download English Presentation (PDF)Download Chinese Presentation (PDF)
Group, RNS Announcements | 3 May 2019

Notice of Extraordinary General Meeting and Shareholders' Circular
London: Friday, May 3, 2019: Hutchison China MediTech Limited (“Chi-Med” or “Company”) (AIM/Nasdaq: HCM) today announces that an Extraordinary General Meeting (“EGM”) is to be held at 11:00 a.m. London time on Wednesday, May 29, 2019. An
Read More
Download Announcement (PDF)
Event | 3 May 2019

Extraordinary General Meeting
Location: 4th Floor, Hutchison House, 5 Hester Road, Battersea, London SW11 4AN, UK Time: 11am    
Read More
Form of Proxy for the EGM (PDF)Notice of Extraordinary General Meeting (PDF)New Memorandum and Articles of Association (PDF)
Regulatory Notice, RNS Announcements | 24 Apr 2019

Results of Annual General Meeting
London: Wednesday, April 24, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that all ordinary resolutions and special resolutions put to its Annual General Meeting (“AGM”) held on April 24, 2019 were duly
Read More
Download Announcement (PDF)
Event | 23 Apr 2019

Deutsche Bank ADR Virtual Investor Conference (dbVIC)
Live virtual investor conference.
Event | 23 Apr 2019

Bank of America Merrill Lynch Health Care Conference 2019
The Encore, Las Vegas, NV, United States
Regulatory Notice, RNS Announcements | 15 Apr 2019

Disclosure Update
London: Monday, April 15, 2019: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) today filed an application (the “Listing Application”) with the Stock Exchange of Hong Kong Limited (“SEHK”) in connection
Read More
Download Announcement (PDF)
Group, RNS Announcements | 15 Apr 2019

Chi-Med Files Application to List in Hong Kong and Announces Proposed Global Offering
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Hong Kong: Monday, April 15, 2019: Hutchison China MediTech
Read More
Download Announcement (PDF)
Innovation Platform, Press Releases, RNS Announcements | 29 Mar 2019

Chi-Med Initiates a Phase IIb/III Trial of Surufatinib in Patients with Unresectable or Metastatic Biliary Tract Cancer in China
London: Friday, March 29, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a registration-enabling Phase IIb/III study comparing surufatinib (HMPL-012 or sulfatinib) with capecitabine in patients with advanced
Read More
Download Press Release (PDF)
Innovation Platform, Press Releases, RNS Announcements | 28 Mar 2019

Chi-Med Highlights Oral Presentations on Savolitinib Lung Cancer Programs at AACR Annual Meeting
Press Release London: Thursday, March 28, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) will share further data on the savolitinib development programs in lung cancer at the American Association of Cancer Research (AACR)
Read More
Download Press Release (PDF)
Event | 25 Mar 2019

Annual General Meeting 2019
Location: 4th Floor, Hutchison House, 5 Hester Road, Battersea, London SW11 4AN, UK Time: 11am  
Read More
Proxy Form for 2019 AGM (PDF)Notice of AGM 2019 (PDF)
Event | 25 Mar 2019

Credit Suisse 22nd Asian Investment Conference
Conrad Hotel, Hong Kong
Event | 25 Mar 2019

Morgan Stanley 9th Annual Hong Kong Investor Summit
Morgan Stanley Office, Hong Kong
Regulatory Notice, RNS Announcements | 25 Mar 2019

Vesting of awards under the Long Term Incentive Plan
London: Monday, March 25, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announces that following the publication of the 2018 annual report of Chi-Med on March 21 2019, the following awards granted under the Long Term Incent
Read More
Download Announcement (PDF)
Financial Reports | 21 Mar 2019

Annual Report 2018 (with Form 20-F)
Contents Corporate Information 2018 Key Highlights Highlights Chairman’s Statement Financial Review Operations Review Biographical Details Of Directors Report of the Directors Corporate Governance Report Form 20-F (Inclu
Read More
Download 2018 Annual Report and Form 20-F (PDF)
Group, RNS Announcements | 21 Mar 2019

2018 Annual Report and Notice of Annual General Meeting
London: Thursday, March 21, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that its 2018 Annual Report together with the Notice of Annual General Meeting and the Form of Proxy have been posted to shareholders
Read More
Download Announcement (PDF)
Group, RNS Announcements | 11 Mar 2019

Publication of Form 20-F
London: Monday, March 11, 2019: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today published the Form 20-F for the financial year ended December 31, 2018. This is available for viewing at http://www.rns-pdf.londonstockexchange.com/r
Read More
View Form 20-F (PDF)
Group, RNS Announcements | 11 Mar 2019

Chi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical Programs
London: Monday, March 11, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces its audited financial results for the year ended December 31, 2018 and provides updates on key clinical programs. Video webcast pr
Read More
Download Announcement (PDF)
Corporate presentations, Event, Presentations | 11 Mar 2019

2018 Full Year Results
Announcement released: 7am BST (3pm HKT / 3am EDT) >> See announcement here Presentation webcast & call: 9am BST (5pm HKT / 5am EDT) >> Click here for the webcast US conference call: 9am EDT (1pm BST/9pm HKT
Read More
Download Presentation (PDF)
Innovation Platform, Press Releases, RNS Announcements | 12 Feb 2019

Chi-Med Highlights Preliminary Phase II Savolitinib / Imfinzi® Combination Data in Advanced Papillary Renal Cell Carcinoma at 2019 ASCO Genitourinary Cancers Symposium
London: Tuesday, February 12, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announced the availability of preliminary results from the Phase II CALYPSO study of the savolitinib / Imfinzi® (durvalumab) combination in
Read More
Download Press Release (PDF)
Event | 8 Feb 2019

WSJ Tech Health
Hotel Nikko San Francisco
Group, RNS Announcements | 8 Feb 2019

Chi-Med to Announce 2018 Final Results
London: Friday, February 8, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) will announce its final results for the year ended December 31, 2018 on Monday, March 11, 2019 at 7:00 am Greenwich Mean Time (GMT). An analyst pr
Read More
Download Announcement (PDF)
1
2345678910111213